CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models-Reference-Cited by-同舟云学术

CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models

Published:2015-05-24 Issue:11 Volume:17 Page:1453-1462
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Chonan Masashi,Saito Ryuta,Shoji Takuhiro,Shibahara Ichiyo,Kanamori Masayuki,Sonoda Yukihiko,Watanabe Mika,Kikuchi Toshiaki,Ishii Naoto,Tominaga Teiji

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/17/11/1453/16665561/nov090.pdf

Reference21 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

2. MGMTGene Silencing and Benefit from Temozolomide in Glioblastoma

3. Identification of human brain tumour initiating cells

4. Preface: antibody therapies for cancer

5. Immune Therapy for Cancer

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A call for clinical trials in glioblastoma multiforme for interleukin 4, interleukin 6, interleukin 13 and CD40;Neurosurgical Review;2024-09-07

2. Interleukin 6 and cancer resistance in glioblastoma multiforme;Neurosurgical Review;2024-09-05

3. Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies;Genes;2024-08-06

4. A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma;Pharmaceuticals;2024-07-23

5. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-05-08